Inst. of Mol. MedicineWelcome
Welcome to the Website of the Institutes of Molecular Medicine and Experimental Immunology!
Our scientific mission is to understand the molecular and cellular mechanisms controlling the immune response in a local fashion to develop either into immunity or immune tolerance. Comprehensive knowledge of the physiological regulation of immune tolerance is required to understand the immuno-pathology of chronic inflammation after infection, autoimmunity and perhaps even failure of the immune response to eliminate tumors. Research groups at IMMEI also join forces to develop novel methods to modulate cell function within tissue using laser-assisted nanoparticle-mediated strategies. Ultimately, we intend to develop new strategies to modulate local immune responses for therapeutic purposes.
News
(Click underlined items for more information)
27.02.2013
Christian Kurts receives Gottfried-Wilhelm-Leibniz-Prize of the DFG
26.02.2012
New transgenic tool to study dendritic cells in vivo published in Nature Methods
29.09.2011
Daniel Engel receives the Fritz-and-Ursula-Melchers Award 2011 of the German Society of Immunology
14.06.2011
Natalio Garbi (German Cancer Research Center) joins the IMMEI as full professor
02.03.2011
Excellence Cluster-Initiative "ImmunoSensation" successful in the first selection round of the DFG
29.11.2010
Immune mechanisms underlying postoperative ileus published in Nature Medicine
10.11.2010
Review Article on hepatic immune tolerance published in Nature Reviews Immunology
27.6.2010
C. Kurts receives Hans-U.-Zollinger-Award of the German Society for Nephrology
1.6.2010
Review Article on Cross-Priming published in Nature Reviews Immunology
30.11.2009
The new website is online!
18.11.2009
Second funding period of SFB704 (Co-speaker Percy Knolle) approved
8.9.2009
Work mechanism of Pioglitazone in experimental encephalomyelitis published in J. Exp. Med.
5.5.2009
KFO228 (Hamburg - Bonn) with participation of the IMMEI approved by the DFG
20.4.2009
New mechanism of glomerulonephritis progression published in J. Clinical Investigation
3.12.2008
SFB TR57 (Aachen-Bonn) with participation of the IMMEI approved by the DFG
4.7.2008
Sven Burgdorf receives Georges-Köhler-Award of the German Society of Immunology
28.3.2008
Cell-biological mechanism of cross-presentation published in Nature Immunology
27.4.2007
Role of Endocytosis mechanisms in cross-presentation published in Science